{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:19:43Z","timestamp":1783210783246,"version":"3.54.6"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017607","name":"Centro de Biologia Molecular Severo Ochoa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022532","name":"Centro Nacional de Biotecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022532","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaci.2026.02.036","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:28:06Z","timestamp":1773073686000},"page":"164-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug screening identifies Src\/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation"],"prefix":"10.1016","volume":"158","author":[{"given":"Maria Jesus","family":"Valle-Pastor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Cayuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge S.","family":"Yebra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis","family":"Senach-Rasilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Pastor-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurea","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Traba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3977-812X","authenticated-orcid":false,"given":"Maria N.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.02.036_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","article-title":"The 3 major types of innate and adaptive cell-mediated effector immunity","volume":"135","author":"Annunziato","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17\u2013producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.02.036_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250348","article-title":"Interleukin 23 receptor: expression and regulation in immune cells","volume":"54","author":"Mezghiche","year":"2024","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib5","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1084\/jem.20060244","article-title":"IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2\u2013dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"Chan","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.02.036_bib6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a TH17 cytokine, mediates IL-23\u2013induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.02.036_bib7","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib8","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1016\/j.celrep.2018.12.012","article-title":"Regulatory T cells restrain pathogenic T helper cells during skin inflammation","volume":"25","author":"Hartwig","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2026.02.036_bib9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.02.036_bib10","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Ror\u03b3t+ innate lymphocytes and \u03b3\u03b4 T cells initiate psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.02.036_bib11","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/jid.2014.98","article-title":"IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing \u03b3\u03b4 T cells","volume":"134","author":"Yoshiki","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.02.036_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/imr.12918","article-title":"From thymus to periphery: molecular basis of effector \u03b3\u03b4-T cell differentiation","volume":"298","author":"Fiala","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2026.02.036_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41590-024-02073-8","article-title":"Signature cytokine-associated transcriptome analysis of effector \u03b3\u03b4 T cells identifies subset-specific regulators of peripheral activation","volume":"26","author":"In\u00e1cio","year":"2025","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib14","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.4049\/jimmunol.1700287","article-title":"IL-1\u03b2 and IL-23 promote extrathymic commitment of CD27+CD122\u2212 \u03b3\u03b4 T cells to \u03b3\u03b4 T17 cells","volume":"199","author":"Muschaweckh","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib15","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.15252\/embr.201744200","article-title":"IL-23 drives differentiation of peripheral \u03b3\u03b417 T cells from adult bone marrow\u2013derived precursors","volume":"18","author":"Papotto","year":"2017","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jaci.2026.02.036_bib16","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1016\/j.celrep.2019.05.019","article-title":"Differential roles of the mTOR-STAT3 signaling in dermal \u03b3\u03b4 T cell effector function in skin inflammation","volume":"27","author":"Cai","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2026.02.036_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaci.2019.09.025","article-title":"Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation","volume":"145","author":"Cibrian","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib18","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.4049\/jimmunol.0900732","article-title":"Cutting edge: IL-23 receptor GFP reporter mice reveal distinct populations of IL-17\u2013producing cells","volume":"182","author":"Awasthi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/ni1008-1091","article-title":"The Immunological Genome Project: networks of gene expression in immune cells","volume":"9","author":"Heng","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib20","doi-asserted-by":"crossref","first-page":"17549","DOI":"10.1073\/pnas.1204327109","article-title":"Interleukin 7 (IL-7) selectively promotes mouse and human IL-17\u2013producing \u03b3\u03b4 cells","volume":"109","author":"Michel","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.02.036_bib21","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3386","article-title":"Psoriasis and treatment: past, present and future aspects","volume":"100","author":"Reid","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2026.02.036_bib22","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R\u03b21 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-020-0435-8","article-title":"Recent insights of T cell receptor\u2013mediated signaling pathways for T cell activation and development","volume":"52","author":"Hwang","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jaci.2026.02.036_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from \u03b3\u03b4 T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.02.036_bib25","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.20111453","article-title":"IL-1\u03b2 mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells","volume":"209","author":"Coccia","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.02.036_bib26","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1038\/ncomms4986","article-title":"Differential developmental requirement and peripheral regulation for dermal V\u03b34 and V\u03b36T17 cells in health and inflammation","volume":"5","author":"Cai","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.02.036_bib27","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1158\/1078-0432.CCR-16-0667","article-title":"Dasatinib reversibly disrupts endothelial vascular integrity by increasing non-muscle myosin II contractility in a ROCK-dependent manner","volume":"23","author":"Kreutzman","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2026.02.036_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/ni.2585","article-title":"Deficiency in IL-17\u2013committed V\u03b34+ \u03b3\u03b4 T cells in a spontaneous Sox13-mutant CD45.1+ congenic mouse substrain provides protection from dermatitis","volume":"14","author":"Gray","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib29","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1073\/pnas.1508990112","article-title":"Inflammation induces dermal V\u03b34+ \u03b3\u03b4 T17 memory-like cells that travel to distant skin and accelerate secondary IL-17\u2013driven responses","volume":"112","author":"Ram\u00edrez-Valle","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.02.036_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.2702","article-title":"Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflammatory \u03b3\u03b4 T cell subsets","volume":"14","author":"Schmolka","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nature13279","article-title":"Focused specificity of intestinal TH17 cells towards commensal bacterial antigens","volume":"510","author":"Yang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.02.036_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000646","article-title":"IL-23 signaling regulation of pro-inflammatory T-cell migration uncovered by phosphoproteomics","volume":"18","author":"\u00c1lvarez-Salamero","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jaci.2026.02.036_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/08923973.2015.1028074","article-title":"Therapeutic effects of dasatinib in mouse model of multiple sclerosis","volume":"37","author":"Azizi","year":"2015","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jaci.2026.02.036_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nbt1046","article-title":"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells","volume":"23","author":"Rush","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2026.02.036_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"pt 2","key":"10.1016\/j.jaci.2026.02.036_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/bj3420287","article-title":"Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide\u2013dependent protein kinase-1: identification of five sites of phosphorylation in vivo","volume":"342","author":"Casamayor","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.jaci.2026.02.036_bib37","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.4049\/jimmunol.1002766","article-title":"Unexpected role for the B cell\u2013specific Src family kinase B lymphoid kinase in the development of IL-17\u2013producing \u03b3\u03b4 T cells","volume":"185","author":"Laird","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tibs.2017.11.008","article-title":"TCR signaling: mechanisms of initiation and propagation","volume":"43","author":"Courtney","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jaci.2026.02.036_bib39","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.3389\/fimmu.2018.03133","article-title":"Treatment effects of the second-generation tyrosine kinase inhibitor dasatinib on autoimmune arthritis","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib40","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/1756-185X.14627","article-title":"Dasatinib, a selective tyrosine kinase inhibitor, prevents joint destruction in rheumatoid arthritis animal model","volume":"26","author":"Min","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaci.2026.02.036_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12967-021-02764-y","article-title":"Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment","volume":"19","author":"Ntari","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.jaci.2026.02.036_bib42","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ibd\/izab196","article-title":"Imatinib and dasatinib-induced ulcerative colitis: case report","volume":"28","author":"Del Sordo","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2026.02.036_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/jclinpath-2022-208340","article-title":"Dasatinib-induced Crohn\u2019s-like colitis","volume":"76","author":"Grillo","year":"2023","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2026.02.036_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2024-263646","article-title":"Dasatinib-induced colitis in a patient with chronic myeloid leukaemia","volume":"18","author":"Gluch","year":"2025","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaci.2026.02.036_bib45","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/pharmaceutics15030736","article-title":"Dasatinib-loaded topical nano-emulgel for rheumatoid arthritis: formulation design and optimization by QbD, in vitro, ex vivo, and in vivo evaluation","volume":"15","author":"Donthi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jaci.2026.02.036_bib46","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.02.036_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.02.036_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","article-title":"Psoriasis","volume":"11","author":"Armstrong","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaci.2026.02.036_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2023.1161799","article-title":"Impact of senolytic treatment on immunity, aging, and disease","volume":"4","author":"Lorenzo","year":"2023","journal-title":"Front Aging"},{"key":"10.1016\/j.jaci.2026.02.036_bib50","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1038\/s41467-021-25453-2","article-title":"Long-term treatment with senolytic drugs dasatinib and quercetin ameliorates age-dependent intervertebral disc degeneration in mice","volume":"12","author":"Novais","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.02.036_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.trsl.2025.02.004","article-title":"Effects of senotherapeutics on gut microbiome dysbiosis and intestinal inflammation in Crohn\u2019s disease: a pilot study","volume":"278","author":"Sangfuang","year":"2025","journal-title":"Transl Res"},{"key":"10.1016\/j.jaci.2026.02.036_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxaf029","article-title":"Senolytic treatment to rescue hallmarks of senescence in lymph node fibroblasts from patients with rheumatoid arthritis: implications for premature aging and potential therapeutic intervention in early rheumatoid arthritis","volume":"219","author":"de Jong","year":"2025","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12964-021-00750-x","article-title":"Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition","volume":"19","author":"Ortiz","year":"2021","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jaci.2026.02.036_bib54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41577-024-01093-7","article-title":"From TCR fundamental research to innovative chimeric antigen receptor design","volume":"25","author":"Minguet","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.02.036_bib55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.immuni.2016.07.022","article-title":"Phosphoproteomic analyses of interleukin 2 signaling reveal integrated JAK kinase-dependent and -independent networks in CD8+ T cells","volume":"45","author":"Ross","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.02.036_bib58","doi-asserted-by":"crossref","unstructured":"R Pal, M Palmieri, A Chaudhury, TJ Klisch, A di Ronza, JR Neilson, et al, Src regulates amino acid-mediated mTORC1 activation by disrupting GATOR1-Rag GTPase interaction. Nat Commun 2018;9:4351.","DOI":"10.1038\/s41467-018-06844-4"},{"key":"10.1016\/j.jaci.2026.02.036_bib59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1593\/neo.07905","article-title":"Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells","volume":"10","author":"Vojtechov\u00e1","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.jaci.2026.02.036_bib60","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/stem.1476","article-title":"Mechanically activated Fyn utilizes mTORC2 to regulate RhoA and adipogenesis in mesenchymal stem cells","volume":"31","author":"Thompson","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.jaci.2026.02.036_bib61","doi-asserted-by":"crossref","unstructured":"Patel CH, Powell JD. More TOR: The expanding role of mTOR in regulating immune responses. Immunity 2025;58:1629\u201345.","DOI":"10.1016\/j.immuni.2025.06.010"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926001740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926001740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:08:04Z","timestamp":1783210084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926001740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0091674926001740"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.02.036","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2025.12.04.692333","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug screening identifies Src\/Abl inhibitor dasatinib as suppressor of IL-23 signaling in skin inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}